In 2005, ECRIN launched ICTD to commemorate the day when James Lind started his famous clinical trial on scurvy in 1747, May 20th, and laid the foundation for modern clinical research. Celebrated every year on or around May 20th, ICTD is an opportunity for research organisations, clinical research professionals, and the public to acknowledge the achievements that result from clinical research and to discuss various trial topics.
ECRIN’s annual celebration of ICTD brings together around 150 European and international stakeholders. Given its success, the conference has been replicated by some of ECRIN’s member/observer countries, who have now introduced their own national/international ICTD celebrations.
For information on the latest ICTD celebration, click here (20 May 2019, Paris)
How to participate? Participation is always free and on a first-come, first-served basis. Registration is mandatory. If you are interested in attending the next ICTD celebration, please email firstname.lastname@example.org
Past ECRIN ICTD Celebrations: Overview
Since ECRIN was awarded 'ERIC' status in 2013, it has continued to hold a yearly celebration of ICTD, typically organised in collaboration with one of its national scientific partners.
In May 2014, the event was held in Luxembourg and focussed on applied clinical trials. In 2015, ECRIN collaborated with its Norwegian national partner (NorCRIN) to organise the ICTD celebration in Trondheim, Norway in May (focussing on transparency).
In 2016, ECRIN held its annual meeting in honour of ICTD in Prague, Czech Republic in May on 'Clinical trials in the era of personalised medicine', organised in collaboration with the Czech national partner (CZECRIN).
In 2017, ECRIN organised ICTD in collaboration with its Portuguese partner (PtCRIN) in Lisbon on the topic of 'Data sharing and reuse: attitudes and practices in multinational clinical research'.
In 2018, ICTD was organised in Budapest in May in collaboration with the Hungarian partner (HECRIN), with a focus on 'Clinical trials and innovation'. In 2019, the event was organised in collaboration with the French partner (F-CRIN) on the topic of 'patient stratification studies', and was held at Luxembourg Palace on 20 May.
Read below for more detailed information on select years.
ECRIN's 2018 celebration of ICTD took place in Budapest, Hungary on 15 May 2018. The theme of the event was ‘Clinical Trials and Innovation'. The aim was to engage with the public, scientific community and decision makers on issues related to (multinational) clinical trials in Europe, and to address issues related to clinical trials and innovation in particular.
ICTD 2018 was organised by ECRIN in collaboration with its Hungarian national scientific partner, the Hungarian European Clinical Infrastructure Network (HECRIN).
The event brought together investigators, patient representatives, national authorities, health technology assessment specialists and other stakeholders involved in multinational clinical studies from across Europe and Hungary.
For more information:
ECRIN's 2017 celebration of ICTD took place in Lisbon, Portugal on 19 May 2017. The theme was ‘Data sharing and reuse: attitudes and practices in multinational clinical research’. The aim was to engage participants in discussion on issues related to data sharing and re-use in particular.
ICTD 2017 was organised by ECRIN in collaboration with its Portuguese national scientific partner, the Portuguese Clinical Research Infrastructure Network (PtCRIN), and the Portuguese National Authority of Medicines and Health Products, I.P. (Infarmed).
The event will brought together investigators, patient representatives, national authorities, health technology assessment specialists and other stakeholders involved in multinational clinical studies from across Europe and Portugal.
The ICTD meeting was followed by a complementary meeting organised by PtCRIN in collaboration with partners. The theme was 'Support to Clinical Trials: Funding, Infrastructures and Investigator Perspectives'.
In celebration of ICTD, ECRIN held a meeting on 'Clinical trials in the era of personalised medicine' on 20 May 2016 in Prague, Czech Republic. The aim was to increase awareness of ECRIN and its Czech national scientific partner – Czech Clinical Research Infrastructure Network (CZECRIN) – among Czech policymakers and the scientific community, as well as to address issues related to personalised medicine and multinational clinical trials.
Held under the auspices of Milan Štěch, the President of the Senate of the Parliament of the Czech Republic, the event was organised by ECRIN and CZECRIN in cooperation with the Czech Committee on Health and Social Policy.
Interviews were conducted with various speakers. To view them, check out the Videos page
Transparency was the theme of ICTD 2015, held in Trondheim, Norway on May 21st, 2015. Click on the links below to see videos of presentations from diverse stakeholders.
- Rita Banzi from the Mario Negri Institute for Pharmacological Research, reviews the Institute of Medicine's 2015 report on transparency
- Kristjan Erlendsson, associate professor of medical education, associate dean of education, University of Iceland Medical Faculty, discusses how to improve regulation and transparency in Nordic clinical research
- Silvio Garattini from the Mario Negri Institute, head of the ECRIN Scientific Board, on ECRIN's experiences with transparency
- Trish Groves, deputy editor, BMJ, and editor in chief, BMJ Open, explains the story and the success of the AllTrials initiative and gives the perspective of scientific journals
- Toby Lasseron, senior editor, Cochrane, presents Cochrane's view on present and future transparency in clinical research
- Andy Powrie-Smith, director – team leader, European Federation of Pharmaceutical Industries and Associations, presents the views of the pharmaceutical industry on transparency
- Gabriela Soskuty, vice president government affairs at B. Braun Melsungen AG, talks about transparency of clinical evidence in medical devices